Previous 10 |
Bemis (NYSE: BMS ) reports U.S. Packaging net sales rose 2.7% to $660.4M in Q4 , driven by price and mix More news on: Bemis Company, Inc., Consumer stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Bemis (NYSE: BMS ): Q4 Non-GAAP EPS of $0.71 in-line; GAAP EPS of $0.70 in-line. More news on: Bemis Company, Inc., Earnings news and commentary, Consumer stocks news, Read more ...
Bemis Company, Inc. (NYSE:BMS) today reported financial results for its fourth quarter and year ended December 31, 2018. Refer to the reconciliation of Non-GAAP measures detailed in the attached schedule, including adjusted earnings per share, adjusted EBITDA, and net debt. SUMMARY...
ABC , ABMD , APO , APRN , APTV , BAX , BC , BHGE , BLL , BMS , BX , CELG , CFR , CHTR , CMCO , CMS , CNX , CNXM , COP , CRR , CRS , DWDP , EPD , ETN , FCFS , FLWS , GE , HSY , IIVI , IP , KEM , KEX , KIM , LANC , MA , MAN , MDC , MIXT , MMC , MMP , M...
Merger activity decreased last week with one new deal announced and one pending deal closing. Deal Statistics: New Deals: The acquisition of UQM Technologies (UQM) by Danfoss Power Solutions (US) Company for $100 million or $1.71 per share in cash. Deal Updates: On Janua...
Bemis (NYSE: BMS ) and Amcor ( OTCPK:AMCRF ) say they have made significant progress towards closing their merger agreement but expect the deal closing to be pushed back to Q2 due to the U.S. government shutdown. More news on: Bemis Company, Inc., Amcor Ltd., Merger & acquisition n...
Amcor Limited (ASX: AMC) and Bemis Company, Inc. (NYSE: BMS) have made significant progress towards closing the all-stock transaction announced on 6 August 2018. Integration planning led by a dedicated team of full time executives from both companies is well underway and preparation of ...
News, Short Squeeze, Breakout and More Instantly...
Bemis Company Inc. Company Name:
BMS Stock Symbol:
NYSE Market:
K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting PR Newswire Poster to be presented Sunday, December 10, 2023 CAMBRIDGE, Mass. , Dec. 4, 2023 /PRNe...
Excellent dividend stocks are great to hold in times of economic downturns. Since the best of the best typically don't suspend -- or even reduce -- their dividend payments regardless of market and economic conditions, the regular and predictable dividend payments can help investors smooth o...
Exelixis (NASDAQ: EXEL) and bluebird bio (NASDAQ: BLUE) are two biotech companies that have been moving in opposite directions on the stock market this year. While Exelixis has provided healthy gains -- its stock is up by 52.1% year to date -- Bluebird's shares have slid by 35.2% since t...